Alliancebernstein L.P. Marker Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$1.88 - $3.56 $55,460 - $105,020	-29,500 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$1.5 - $2.2 $3,450 - $5,060	-2,300 Reduced 7.23%	29,500 $44,000
Q2 2020 Aug 13, 2020	BUY	$1.69 - $2.79 $9,633 - $15,903	5,700 Added 21.84%	31,800 $66,000
Q1 2020 May 14, 2020	BUY	$1.59 - $3.35 $477 - $1,005	300 Added 1.16%	26,100 $50,000
Q3 2019 Nov 14, 2019	BUY	$4.1 - $9.0 $29,519 - $64,800	7,200 Added 38.71%	25,800 $132,000
Q2 2019 Aug 14, 2019	BUY	$5.15 - $7.92 $95,790 - $147,312	18,600 New	18,600 $147,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $163M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.